Search the Community
Showing results for tags 'legal action'.
Found 3 results
I was just wondering if anyone here has ever attempted or is considering taking legal action against the doctor(s) who made their "diagnosis", prescribed their "meds" and/or who claimed the drugs were non-addictive. I for one have considered it and discussed it briefly with an acquaintance who is a lawyer. However, according to him it would be almost impossible to win such a case in court with the main problem being able to prove without a doubt that the doctor in question made a mistake (from a legal point of view, that is). Then there's the financial issue, of course. Going to court with such a case would cost an incredible amount of money. So, as pointless as it seems to be to consider the legal route, has anyone actually given it a shot? I presume not, by the way, but thought I might raise the question nonetheless. Also, I do not want to start a heated debate about how we've all been wronged and about what a bunch of [expletive deleted] psychiatrists are... That's a given, of course. I'm only asking because, who knows, maybe someone here has had some success in that regard or knows how one could go about it (at least in theory).
Fresh posted a topic in In the mediaREUTERS: http://www.reuters.com/article/2015/08/03/us-eli-lilly-cymbalta-trial-idUSKCN0Q825220150803 Health | Mon Aug 3, 2015 4:16pm EDT Related: HEALTH Eli Lilly faces first U.S. trials over Cymbalta withdrawal NEW YORK | BY JESSICA DYE Eli Lilly & Co on Tuesday will confront the first U.S. trial over allegations it failed to warn users of its popular antidepressant Cymbalta that they could suffer severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations. Plaintiff Claudia Herrera is one of about 250 people who have sued Lilly over Cymbalta, and the company faces three more trials later this month involving similar claims, according to a lawyer for Herrera, R. Brent Wisner. These early trials will be a critical test for litigation over the drug, which had $3.9 billion in sales in 2013 before losing patent protection at the end of that year and brought in $561 million in the first half of 2015. Cymbalta, part of a class of antidepressants known as serotonin and norepinephrine reuptake inhibitors, was approved by the U.S. Food and Drug Administration in 2004 to treat major depressive disorder. Later, approval was expanded to include generalized anxiety disorder and fibromyalgia. Its label warns that 1 percent or more of users who discontinue Cymbalta may experience symptoms like nausea, irritability and insomnia, and that other symptoms such as sensory disturbances and seizures had been reported. But plaintiffs suing Lilly allege that withdrawal symptoms are far more common, pointing to a 2005 analysis from the Journal of Affective Disorders that found more than 44 percent of patients reported at least one discontinuation symptom. A Lilly spokeswoman declined to comment specifically on Herrera’s allegations and said that the company would vigorously defend that case and others. According to Herrera’s lawsuit in California federal court, she started taking Cymbalta in 2006 for anxiety. When her doctor instructed her in 2012 to ease off gradually, she said that she suffered electric-like “zaps,” anxiety, spasms and suicidal ideation, among other symptoms. Herrera accused Lilly of downplaying its warnings to make the drug more marketable. Lilly said in court filings that it gave sufficient warnings, and that her doctor was aware of the potential risks. A similar case is set for trial in California starting Aug. 11. Other Cymbalta lawsuits have been less successful. A New York judge last year granted Lilly a win in a case similar to Herrera's and twice, a federal judge in California has denied plaintiffs’ motions for class certification on consumer-protection claims related to Cymbalta marketing. The California trials, and two more scheduled to start in Virginia in late August, will be the first opportunities for juries to evaluate the underlying claims. “The success or failure of these cases will give us a good sense of how they are playing to these juries,” Wisner said. “Even if we lose, we have every intention of moving forward with the litigation.”
Fresh posted a topic in Events, controversies, actionsFREE LEGAL HELP Studies show that between 50% and 78% of Cymbalta users experience antidepressant withdrawal symptoms after discontinuing the drug. Yet the drug label misleadingly states that Cymbalta withdrawal symptoms occur in only 1% to 2% of cases. These findings have resulted in nearly three dozen Cymbalta lawsuits and a Cymbalta class action lawsuit against Eli Lilly and Co. for allegedly misleading consumers about the risk and severity of Cymbalta withdrawal side effects. If you attempted to stop taking Cymbalta and suffered withdrawal symptoms such as brain “zaps” (electric-like sensations in the body and brain), nausea, vomiting, diarrhea, vertigo, dizziness, hot and cold flashes, insomnia, nightmares or more, you may have a legal claim. Join a Free Cymbalta Class Action Lawsuit Investigation If you qualify, an attorney will contact you to discuss the details of your potential case at no charge to you. Due to the high volume of interest in filing a Cymbalta withdrawal lawsuit it may take 7 – 14 business days to receive a response from the attorneys handling these submissions. Please be patient. The law firm responsible for this investigation is reviewing every single submission that comes in. Go to: http://topclassactions.com/lawsuit-settlements/lawsuit-news/40648-cymbalta-withdrawal-side-effects-class-action-lawsuit-investigation/